Octave Specialty (OSG) Current Deferred Revenue (2010 - 2026)

Octave Specialty's Current Deferred Revenue history runs 17 years deep, the most recent figure standing at $198.7 million for Q1 2026.

• In Q1 2026, Current Deferred Revenue rose 9.53% year-over-year to $198.7 million; the TTM figure through Mar 2026 stood at $198.7 million (up 9.53% YoY), while the FY2025 annual figure was $187.2 million, up 2.59% from the prior year.
• Current Deferred Revenue was $198.7 million for Q1 2026 at Octave Specialty, up from $187.2 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $458.0 million in Q3 2024 to a low of $85.4 million in Q4 2022.
• Historically, Current Deferred Revenue has averaged $296.3 million across 5 years, with a median of $359.0 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue slumped 77.81% in 2022, then soared 81.32% in 2023.
• A 5-year view of Current Deferred Revenue shows it stood at $85.4 million in 2022, then soared by 81.32% to $154.9 million in 2023, then advanced by 17.8% to $182.4 million in 2024, then climbed by 2.59% to $187.2 million in 2025, then grew by 6.15% to $198.7 million in 2026.
• The last three Current Deferred Revenue figures came in at $198.7 million (Q1 2026), $187.2 million (Q4 2025), and $197.1 million (Q3 2025), per Business Quant data.